Thirty Years of Research on the Dawn Phenomenon: Lessons to Optimize Blood Glucose Control in Diabetes

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2013 Nov 23

PMID 24265365

Citations 36

Authors

Francesca Porcellati

Paola Lucidi

Geremia B Bolli

Carmine G Fanelli

Affiliations

Soon will be listed here.

Citing Articles

Impact of early-morning administration of rapid-acting insulin on the increase in blood glucose levels related to the dawn phenomenon in individuals with type 1 diabetes.

Takayoshi T, Hirota Y, Yamamoto A, Yoshimura K, Nishikage S, Ueda M Diabetol Int. 2024; 15(3):433-438.

PMID: 39101193 PMC: 11291825. DOI: 10.1007/s13340-024-00709-6.

supplementation improves glucose tolerance in intestinal knockout mice during the daily light to dark transition.

Wang Z, Cui S, Zhang T, Wang W, Li J, Chen Y mSystems. 2023; 8(5):e0057323.

PMID: 37787527 PMC: 10654094. DOI: 10.1128/msystems.00573-23.

Uncovering personalized glucose responses and circadian rhythms from multiple wearable biosensors with Bayesian dynamical modeling.

Phillips N, Collet T, Naef F Cell Rep Methods. 2023; 3(8):100545.

PMID: 37671030 PMC: 10475794. DOI: 10.1016/j.crmeth.2023.100545.

Diurnal Cycling of Insulin Sensitivity in Type 2 Diabetes: Evidence for Deviation From Physiology at an Early Stage.

Lucidi P, Perriello G, Porcellati F, Pampanelli S, De Fano M, Tura A Diabetes. 2023; 72(10):1364-1373.

PMID: 37440717 PMC: 10866740. DOI: 10.2337/db22-0721.

Confirmation of the Absence of Somogyi Effect in Patients with Type 2 Diabetes by Retrospective Continuous Glucose Monitoring Systems.

Huang Y, Lou X, Huang W, Qiu J, Jiang C, Sun J Int J Endocrinol. 2022; 2022:6599379.

PMID: 36237834 PMC: 9553369. DOI: 10.1155/2022/6599379.

References

Brennan J, Gebhart S, BLACKARD W . Pump-induced insulin aggregation. A problem with the Biostator. Diabetes. 1985; 34(4):353-9. DOI: 10.2337/diab.34.4.353. View

Schmidt M, Hadji-Georgopoulos A, Rendell M, Margolis S, KOWARSKI A . The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation. Diabetes Care. 1981; 4(6):579-85. DOI: 10.2337/diacare.4.6.579. View

De Feo P, Perriello G, Ventura M, Calcinaro F, Basta G, Lolli C . Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon. Diabetologia. 1986; 29(8):475-80. DOI: 10.1007/BF00453496. View

Perriello G, De Feo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P . The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity. Diabetologia. 1991; 34(1):21-8. DOI: 10.1007/BF00404020. View

Perriello G, De Feo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P . Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia. 1990; 33(1):52-9. DOI: 10.1007/BF00586461. View

Kruszynska Y, Home P . Night-time metabolic changes in normal subjects in the absence of the dawn phenomenon. Diabete Metab. 1988; 14(4):437-42. View

Radziuk J, Pye S . Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour?. Diabetologia. 2006; 49(7):1619-28. DOI: 10.1007/s00125-006-0273-9. View

Gerstein H, Bosch J, Dagenais G, Diaz R, Jung H, Maggioni A . Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med. 2012; 367(4):319-28. DOI: 10.1056/NEJMoa1203858. View

Monnier L, Colette C, Dejager S, Owens D . Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern?. Diabetes Care. 2013; 36(12):4057-62. PMC: 3836163. DOI: 10.2337/dc12-2127. View

10.

Bolli G, Gerich J . The "dawn phenomenon"--a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N Engl J Med. 1984; 310(12):746-50. DOI: 10.1056/NEJM198403223101203. View

11.

Schmidt M, Lin Q, Gwynne J, Jacobs S . Fasting early morning rise in peripheral insulin: evidence of the dawn phenomenon in nondiabetes. Diabetes Care. 1984; 7(1):32-5. DOI: 10.2337/diacare.7.1.32. View

12.

Monnier L, Colette C, Dunseath G, Owens D . The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care. 2007; 30(2):263-9. DOI: 10.2337/dc06-1612. View

13.

Perriello G, Pampanelli S, Del Sindaco P, Lalli C, Ciofetta M, Volpi E . Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes. 1997; 46(6):1010-6. DOI: 10.2337/diab.46.6.1010. View

14.

Boden G, Chen X, Urbain J . Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. Diabetes. 1996; 45(8):1044-50. DOI: 10.2337/diab.45.8.1044. View

15.

Bending J, Pickup J, Collins A, Keen H . Rarity of a marked "dawn phenomenon" in diabetic subjects treated by continuous subcutaneous insulin infusion. Diabetes Care. 1985; 8(1):28-33. DOI: 10.2337/diacare.8.1.28. View

16.

Bolli G, De Feo P, De Cosmo S, Perriello G, Ventura M, Calcinaro F . Demonstration of a dawn phenomenon in normal human volunteers. Diabetes. 1984; 33(12):1150-3. DOI: 10.2337/diab.33.12.1150. View

17.

Owens D, Bolli G . Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application. Diabetes Technol Ther. 2008; 10(5):333-49. DOI: 10.1089/dia.2008.0023. View

18.

Monnier L, Colette C, Sardinoux M, Baptista G, Regnier-Zerbib A, Owens D . Frequency and severity of the dawn phenomenon in type 2 diabetes: relationship to age. Diabetes Care. 2012; 35(12):2597-9. PMC: 3507613. DOI: 10.2337/dc12-0385. View

19.

Campbell P, Bolli G, Cryer P, Gerich J . Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. N Engl J Med. 1985; 312(23):1473-9. DOI: 10.1056/NEJM198506063122302. View

20.

Inzucchi S, Bergenstal R, Buse J, Diamant M, Ferrannini E, Nauck M . Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012; 35(6):1364-79. PMC: 3357214. DOI: 10.2337/dc12-0413. View